Note 3. Segment Information (Tables)

12 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Fiscal Year Ended March 31,	Medical			Industrial			Adjustments*			Consolidated
2013
Net sales	$	11,630		$	3,657		$	-		$	15,287
Gross profit		3,102			1,240			-			4,342
Operating loss		(8,381	)		(96	)		-			(8,477	)
Depreciation and amortization		772			23			-			795
Assets		11,833			1,466			(1,922	)		11,377
Expenditures for fixed assets		95			-			-			95
2012
Net sales	$	13,735		$	2,951		$	-		$	16,686
Gross profit		4,064			1,021			-			5,085
Operating loss		(9,868	)		(247	)		-			(10,115	)
Depreciation and amortization		789			43			-			832
Assets		13,140			1,413			(1,954	)		12,599
Expenditures for fixed assets		209			-			-			209

Segment Reporting, Measurement Differences Between Segment and Consolidated Profit (Loss)

	March 31,
*Adjustments	2013			2012
Intercompany eliminations	$	(1,236	)	$	(1,268	)
Investment in subsidiaries		(686	)		(686	)
Total adjustments	$	(1,922	)	$	(1,954	)

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

	Fiscal Year Ended March 31,
	2013			2012
Operating loss	$	(8,477	)	$	(10,115	)
Interest expense, net		(499	)		(480	)
Debt cost expense		(272	)		(372	)
Loss on extinguishment of debt		(1,244	)		-
Other, net		(53	)		(48	)
Loss before provision for income taxes	$	(10,545	)	$	(11,015	)

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	Fiscal Year Ended March 31,
	2013				2012
United States	$	10,296	67	%	$	11,349	68	%
Europe		3,527	23	%		3,700	22	%
Canada		471	3	%		303	2	%
Middle East and Africa		468	3	%		371	2	%
Asia and Australia		345	2	%		885	5	%
Central and South America		180	2	%		78	1	%
Net sales	$	15,287	100	%	$	16,686	100	%